SAN DIEGO--(BUSINESS WIRE)--CRISPR QC, a pioneering biotechnology company in San Diego, is excited to announce the launch of several groundbreaking products designed to revolutionize the field of gene ...
The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...
CRISPR Therapeutics has upcoming catalysts and a strong cash position, making it a solid investment opportunity. The company's pipeline includes therapies for diabetes, immuno-oncology, and ...
Five years ago this month, in November 2020, medical history was made at London-based contract research organisation, Richmond Pharmacology, when a patient received the first CRISPR therapy delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback